Elaine M Wood, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 226 W Kytle St, Suite B, Cleveland, GA 30528 Phone: 706-219-1998 Fax: 706-219-2038 |
News Archive
A Queen's University Belfast expert is leading a €4m international initiative to investigate whether natural toxins and manmade chemicals are creating potentially dangerous mixtures that affect our natural hormones and cause major illnesses such as cancer, obesity, diabetes or infertility.
Royal Philips , a global leader in health technology, has launched its DigitalDiagnost C90, a new ceiling-suspended digital radiography system. The system offers a live tube camera, versatile room configuration capabilities and exam automation technologies that work harmoniously to provide improved patient and Radiographer experiences.
Pregabalin, FDA-approved for neuropathic pain (pain caused by shingles and peripheral neuropathy), effectively reduced abdominal pain and improved sleep in women with adhesions, according to a Henry Ford study.
Rural households in developing countries often rely on burning biomass, such as wood, animal dung and waste from agricultural crops, to cook and heat their homes. The practice is long known to cause lung disease, but a new study from Washington University School of Medicine in St. Louis and Johns Hopkins University School of Medicine links the resulting smoke to cardiovascular problems, including an increase in artery-clogging plaques, artery thickness and higher blood pressure.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
› Verified 6 days ago